Carnosine dipeptidase 2 (CNDP2) represents an attractive therapeutic target because of its roles in maintaining intracellular cysteine availability for glutathione synthesis and supporting tumor cell proliferation through nutrient recycling. This evidence concerns the gene CNDP2 and neoplasm.